Alessandro Caracciolo

TL;DR: The ischemic injury caused by myocardial infarction activates a complex healing process wherein a powerful inflammatory response and a reparative phase follow and balance each other.

TL;DR: This study represents a unique opportunity to further investigate the role of ECGs in the diagnosis and risk stratification of ACS patients with or without ST-segment deviation, as well as to assess whether the radial approach and bivalirudin may affect post-treatment ECG metrics and patterns in a large contemporary ACS population.

TL;DR: The evidence regarding antithrombotic therapy for secondary prevention in coronary artery disease and stent implantation is revised, the complex interrelation between antiplatelet and anticoagulant therapy in patients undergoing percutaneous coronary intervention with concomitant atrial fibrillation is reviewed, and the novel developments in the secondary prevention after structural heart disease intervention are focused on.

TL;DR: Personalized antithrombotic therapy for the patient’s specific characteristics is advisable to account for the elevated ischemic and bleeding risk of patients with chronic kidney disease.

TL;DR: A low inter-observer agreement in diagnosis of type 2 BP in categories of cardiologists with different abilities is demonstrated for the first time, highlighting the difficulties in analysis of ECG with BrS suspicion and underscore the key role of clinical and anamnestic data.